Diabetes Mellitus and Metformin Are Not Associated With Breast Cancer Pathologic Complete Response
Metformin use has been linked to pathologic complete response (pCR) following neoadjuvant chemotherapy for several malignancies. We aimed to investigate the association of diabetes mellitus (DM) and metformin use with pCR in breast cancer.
Source: Journal of Surgical Research - Category: Surgery Authors: Taryn E. Hassinger, Adam C. Berger, Adrienne Christopher, Anne T. Knisely, J. Hunter Mehaffey, David R. Brenin, Anneke T. Schroen, Shayna L. Showalter Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Diabetes | Diabetes Mellitus | Endocrinology | Fortamet | Metformin | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Surgery